Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Qian‐Wen Rao"'
Autor:
Qian‐Wen Rao, Shi‐Long Zhang, Meng‐Zhou Guo, Fei‐Fei Yuan, Jia‐Lei Sun, Feng Qi, Li‐Shun Wang, Bi‐Wei Yang, Jing‐Lin Xia
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8318-8332 (2020)
Abstract Identifying novel prognostic biomarkers for hepatocellular carcinoma (HCC) and then, develop an effective individualized treatment strategy remain extremely warranted. The prognostic role of sulfiredoxin‐1(SRXN1), an antioxidant enzyme, re
Externí odkaz:
https://doaj.org/article/b1a898b1497a4c7db20669cd7a2535a5
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Systemic sclerosis (SSc) is an immune-mediated connective tissue disease characterized by fibrosis of multi-organs, and SSc-related interstitial lung disease (SSc-ILD) is a leading cause of morbidity and mortality. To explore molecular biological mec
Externí odkaz:
https://doaj.org/article/0e91660a7fcf4fe6ab051cdb2c71b44c
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Aim: The objective of our study was to investigate the epidemiologic characteristics, prognostic factors and survival in patients with primary hepatic lymphoma (PHL).Methods: PHL patients diagnosed between 1983 and 2015 were identified from the SEER
Externí odkaz:
https://doaj.org/article/f66b990a2299416e9d086094aee33df1
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Frontiers in Genetics
Frontiers in Genetics
Systemic sclerosis (SSc) is an immune-mediated connective tissue disease characterized by fibrosis of multi-organs, and SSc-related interstitial lung disease (SSc-ILD) is a leading cause of morbidity and mortality. To explore molecular biological mec
Autor:
Jialei Sun, Peixin Huang, Qian-Wen Rao, Jinglin Xia, Mengzhou Guo, Feng Qi, Biwei Yang, Feifei Yuan, Zhiying Zhao, Tingting Fang
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-13 (2020)
Background Fibrinogen-like protein 1 (FGL1)—Lymphocyte activating gene 3 (LAG-3) pathway is a promising immunotherapeutic target and has synergistic effect with programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1). However, the prognostic si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::111fbd9aaed40b9165a1513115a74c31
https://doi.org/10.21203/rs.3.rs-19039/v2
https://doi.org/10.21203/rs.3.rs-19039/v2
Autor:
Mengzhou Guo, Li-Shun Wang, Jialei Sun, Jinglin Xia, Shi-Long Zhang, Qian-Wen Rao, Feng Qi, Biwei Yang, Feifei Yuan
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 22, Pp 8318-8332 (2020)
Cancer Medicine, Vol 9, Iss 22, Pp 8318-8332 (2020)
Identifying novel prognostic biomarkers for hepatocellular carcinoma (HCC) and then, develop an effective individualized treatment strategy remain extremely warranted. The prognostic role of sulfiredoxin‐1(SRXN1), an antioxidant enzyme, remains unk
Publikováno v:
Journal of Biomedicine. 2:45-56
IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner
Autor:
Jinglin Xia, Peixin Huang, Qian-Wen Rao, Donghe Li, Jialei Sun, Tingting Fang, Zhiying Zhao, Feng Qi, Biwei Yang, Feifei Yuan, Mengzhou Guo
Publikováno v:
Biochemical and biophysical research communications. 523(3)
Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide that responds poorly to existing therapies. The Casein kinase 1 (CK1) isoforms CK1δ and CK1e are reported to be highly expressed in several tumor types, and both genetic and